EPHB2 and breast carcinoma: In MCF-7 breast cancer cells, on the other hand, EphB4 displayed pro-oncogenic effects, via ephrin-B2-mediated activation of the extracellular signal-regulated kinase (ERK) pathway, which has been linked to the promotion of protein phosphatase [60].